Advertisement

Generalized lymphatic malformation with chylothorax: Long-term management of a highly morbid condition in a pediatric patient

      Abstract

      Generalized lymphatic malformation (GLM) often causes chylothorax, which can be a highly morbid condition. Chylothorax in a pediatric patient with a lymphangiogenic disorder may be especially resistant to therapy, requiring more aggressive measures. We discuss the complex ongoing long-term management of a pediatric patient with GLM who presented with massive, persistent left chylothorax, which resolved by surgical ligation of the thoracic duct and medical management.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee W.S.
        • Kim S.H.
        • Kim I.
        • et al.
        Chylothorax in Gorham's disease.
        J Korean Med Sci. 2002; 17: 826-829
        • Ono S.
        • Iwai N.
        • Chiba F.
        • et al.
        OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations.
        J Ped Surg. 2010; 45: E7-E10
        • Sanlialp I.
        • Karnak I.
        • Tanyel F.C.
        • et al.
        Sclerotherapy for lymphangioma in children.
        Int J Pediatr Otorhinolaryngol. 2003; 67: 795-800
        • Kadota Y.
        • Utsumi T.
        • Kawamura T.
        • et al.
        Lymphatic and venous malformation or “lymphangiohemangioma” of the anterior mediastinum: a case report and literature review.
        Gen Thorac Cardiovasc Surg. 2011; 59: 575-578
        • Duyka L.J.
        • Fan C.Y.
        • Coviello-Malle J.M.
        • et al.
        Progesterone receptors identified in vascular malformations of the head and neck.
        Otolaryngol Head Neck Surg. 2009; 141: 491-495
        • Chavanis N.
        • Chaffanjon P.
        • Frey G.
        • et al.
        Chylothorax complicating Gorham's disease.
        Ann Thorac Surg. 2001; 72: 937-939
        • Tie M.L.
        • Poland G.A.
        • Rosenow III, E.C.
        Chylothorax in Gorham's syndrome. A common complication of a rare disease.
        Chest. 1994; 105: 208-213
        • Fairfax A.J.
        • Mc Nabb W.R.
        • Spiro S.G.
        Chylothorax: a review of 18 cases.
        Thorax. 1986; 41: 880-885
        • Sassoon C.S.
        • Light R.W.
        Chylothorax and pseudochylothorax.
        Clin Chest Med. 1985; 6: 163-171
        • Goorwitch J.
        Traumatic chylothorax and thoracic duct ligation.
        J Thorac Surg. 1955; 29: 467-479
        • Kery L.
        • Wouters H.W.
        Massive osteolysis: report of two cases.
        J Bone Joint Surg. 1970; 52-B: 452-459
        • Miller G.
        Treatment of chylothorax in Gorham's disease: case report and literature review.
        Can J Surg. 2002; 45: 381-382
        • Deso S.
        • Ludwig B.
        • Kabutey N.K.
        • et al.
        Lymphangiography in the diagnosis and localization of various chyle leaks.
        Cardiovasc Intervent Radiol. 2012; 35: 117-126
        • Momose M.
        • Kawakami S.
        • Koizumi T.
        • et al.
        Lymphoscintigraphy using technetium-99 m HSA-DTPA with SPECT/CT in chylothorax after childbirth.
        Radiat Med. 2008; 26: 508-511
        • Fujiu K.
        • Kanno R.
        • Suzuki H.
        • et al.
        Chylothorax associated with massive osteolysis (Gorham's syndrome).
        Ann Thorac Surg. 2002; 73: 1956-1957
        • Choma N.D.
        • Biscotti C.V.
        • Bauer T.W.
        • et al.
        Gorham's syndrome: a case report and review of the literature.
        Am J Med. 1987; 83: 1151-1156
        • Barnes N.L.P.
        • Warnberg F.
        • Farnie G.
        • et al.
        Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
        Br J Cancer. 2007; 96: 575-582
        • Klenke F.M.
        • Gebhard M.M.
        • Ewerbeck V.
        • et al.
        The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.
        BMC Cancer. 2006; 6: 9
        • Vignot S.
        • Faivre S.
        • Aguirre D.
        • et al.
        mTOR-targeted therapy of cancer with rapamycin derivatives.
        Ann Oncol. 2005; 16: 525-537
        • Makinen T.
        • Veikkola T.
        • Mustjoki S.
        • et al.
        Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
        EMBO J. 2001; 20: 4762-4773
        • Salameh A.
        • Galvagni F.
        • Bardelli M.
        • et al.
        Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways.
        Blood. 2005; 106: 3423-3431
        • Hammill A.M.
        • Wentzel M.
        • Gupta A.
        • et al.
        Sirolimus for the treatment of complicated vascular anomalies in children.
        Pediatr Blood Cancer. 2011; 57: 1018-1024